Why this matters for your runway: Traditional animal toxicology is often slow, expensive, and-lets be honest-frequently fails to predict human safety outcomes
Improved metabolic markers suggest the medication is working, but unchanged markers could mean the product is inactive OR that your body is not responding, and blood work alone cannot differentiate between these possibilities
Loos, a professor at the University of Copenhagen and affiliated with a research center supported by the Novo Nordisk Foundation (the maker of Wegovy and Ozempic), noted, "The current model explains only 25% of the variability, and further research is needed to uncover the remaining 75%." However, she also expressed optimism, stating, "By combining genetic and clinical information, the era of personalized medicine, where we can select the best drug for each patient, may be upon us."
The ideal female HRT candidate is a symptomatic woman within 10 years of menopause onset or under age 60, without contraindications such as a history of breast cancer, venous thromboembolism, or active liver disease
And this includes the immune system